Rheumatoid arthritis (RA) is an autoimmune disorder in which the immune system attacks the body. This then that causes inflammation of the lining of the joints. Over time, damage to the bones will result in bone erosion and deformity. RA is a whole body disease that can affect organs outside the joints as well, such as the eyes, lungs, blood vessels and skin.  In a study, 61% of patients with RA and 76% of dermatologists reported skin abnormalities.  While this disorder can cause discomfort, in most cases, it can be treated or managed.
The information on this site is provided by physicians experienced in the treatment of inflammatory rheumatic diseases with low dose antibiotics according to the protocol developed by the late Dr. Thomas McPherson Brown, . and by many of the multiple thousands of patients who have benefited from this treatment. The website includes all the information necessary to administer this therapy. Physicians should not attempt antibiotic therapy until they have read the protocol completely as this therapy is unlike any other they may be currently using. There are many components to these diseases and their treatment and antibiotic therapy must be tailored to the individual. Treatment periods are usually long and medication and dosage adjustments may be required.
Biologic drugs: abatacept ( Orencia ), adalimumab ( Humira ), anakinra ( Kineret ), certolizumab (Cimzia), etanercept ( Enbrel ), etanercept-szzs (Ereizi), golimumab (Simponi, Simponi Aria ), and infliximab ( Remicade ). These are the newest drugs for RA and are either injected under the skin or given directly into a vein. They work by neutralizing one of the immune system's signals (TNF) that lead to inflammation and joint damage. Rituximab ( Rituxan ) and tocilizumab (Actemra) are biologics, but do not block TNF. Rituxan target B cells and actemra affects IL-6. When used with methotrexate, these medicines help most people with rheumatoid arthritis . These drugs are thought to have fewer side effects than other DMARDs. One side effect is the risk for potentially severe infections. These medicines can also, although rarely, adversely affect your liver or blood counts. Other potential long-term effects won't be known until the drugs have been used by patients for many years.